Glycogen Storage Disease Type II (GSD II)

Explore clinical trials studying Glycogen Storage Disease Type II (GSD II). Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Glycogen Storage Disease Type II (GSD II) trial results

Completed

NCT01898364

Conditions: Acid Maltase Deficiency, Brain Diseases, Brain Diseases, Metabolic, +15 more
Locations: Investigational Site Number 840006 Phoenix, Arizona, United States

Investigational Site Number 840010 Jacksonville, Florida, United States

Investigational Site Number 840001 Kansas City, Kansas, United States

Investigational Site Number 840008 St Louis, Missouri, United States

View all 17 locations

Completed

NCT01410890

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations: Investigational Site Number 840008 Valhalla, New York, United States

Investigational Site Number 840007 Cincinnati, Ohio, United States

Investigational Site Number 840005 Salt Lake City, Utah, United States

Investigational Site Number 840003 Fairfax, Virginia, United States

Completed

NCT01288027

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations: Orange, California, United States

Gainesville, Florida, United States

Kansas City, Kansas, United States

St Louis, Missouri, United States

View all 15 locations

Completed

NCT00731081

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations: Pitie-Salpetriere Hospital Paris, France